MHRA Updated NIMAR Guidance to reflect Windsor Framework

Nov 24, 2023 | Acorn Regulatory News

The Northern Ireland MHRA Authorised Route (NIMAR) provides a route for the lawful supply of POMs in compliance with UK and EU rules, where there is a risk that clinical need in NI for that product cannot be met. MHRA has updated their NIMAR guidance to reflect the Windsor Framework. They have confirmed the NIMAR process is still in place and likely will not be required once the Windsor Framework will come into effect. Under the Windsor framework, from January 2025 ‘PL GB’ packs will be allowed to be sold to Northern Ireland. For more information, click here.

Read More

  More Blog Posts

BioPharmaChem Impact 24 Conference

BioPharmaChem Impact 24 Conference

We were delighted to attend the 1st ever BioPharmaChem Impact 24 Conference which took place yesterday May 23rd in the beautiful surroundings of Fota Island Resort, Cork.

read more

Strategy

Subscribe to Our Newsletter

Sign up for our newsletter today and stay informed on the latest regulatory updates and industry insights.